PD-1 inhibitors belong to a class of medications known as immune checkpoint inhibitors, which have become an important part of many modern cancer treatment plans. PD-1 inhibitors work by helping the ...
Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...
A triple-drug therapy for pancreatic cancer has shown promise in early animal tests, pointing to a potential new treatment for a disease with a notoriously low survival rate. Considered one of the ...
News Medical on MSN
Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the scientific journal ...
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company’s Phase 2, ...
Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The ...
Researchers at Moffitt Cancer Center have developed a new mouse model that more accurately reflects how uveal melanoma acts in humans. This could improve research, resulting in better patient outcomes ...
The ‘MYCN’ gene creates a specific nook that turns healthy liver cells into cancer. Detecting MYCN gene early could help identify and reduce liver cancer risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results